Deregulation of RNA polymerase III (Pol III) transcription enhances cellular tRNAs and 5S rRNA production, leading to an increase in translational capacity to promote cell proliferation, transformation and tumor formation. Phosphorylation of histone H3 (H3ph) is induced by tumor promoters (EGF, UV and TPA) and immediate early genes, such as c-myc, c-jun and c-fos. However, it remains to be determined whether H3ph is involved in RNA Pol III transcription. Here, we report that EGF strongly induced H3ph at serine 28 (H3S28ph). EGF significantly increased transcription of RNA Pol III-dependent genes (Pol III genes), tRNA Leu , tRNA Tyr , 5S rRNA and 7SL RNA. Inhibition of EGFR, but not PI3K, reduced both H3S28ph and tRNA Leu and 5S rRNA transcription. EGF enhanced occupancy of H3S28ph in the promoters of tRNA Leu and 5S rRNA. Further analysis indicates that EGF augmented cellular levels of protein and mRNA of TFIIIB subunits, Brf1 and TATA box-binding protein (TBP). Brf1 is a specific transcription factor for RNA Pol III genes. EGF enhanced occupancy of H3S28ph in the Brf1 and TBP promoters. Inhibition of H3S28ph by mutant H3S28A repressed Brf1, TBP and tRNA Leu and 5S rRNA expression and decreased occupancy of H3S28ph in their promoters. Reduction of Brf1 significantly decreased tRNA Leu and 5S rRNA transcription and repressed EGF-induced anchorageindependent growth. Blocking H3S28ph signaling by using mutant H3S28A reduced EGF-induced cell transformation. Together, these results indicate that EGF activates EGFR signaling to induce H3S28ph, which, in turn, upregulates tRNA Leu and 5S rRNA transcription through Brf1 and TBP and promotes cell transformation. The studies demonstrate that epigenetic modification of H3S28ph has a critical role in the activity of Pol III genes.
Introduction
RNA polymerase (Pol) III transcribes a variety of untranslated RNAs, including tRNAs, 5S rRNAs, 7SL RNA, 7SK RNA and U6 RNA (Ullu and Tschudi, 1984; Dieci et al., 2007; Raha et al., 2010) , whereas tRNA and 5S rRNA control the translational and growth capacity of cells (White, 2004; Goodfellow et al., 2006) . Oncogenic proteins, such as Ras, c-Jun, and c-Myc, stimulate RNA Pol III-dependent gene (Pol III gene) transcription (Zhong et al., 2004; ; tumor suppressors, such as pRb, p53, PTEN and Maf1 repress transcription of this class of genes (White, 2004; Woiwode et al., 2008; . Studies have indicated that RNA Pol III transcription products are elevated in both transformed and tumor cells suggesting that they have a crucial role in tumorigenesis (Winter et al., 2000; White, 2004) . Consistent with this idea, enhanced Pol III transcription is required for oncogenic transformation , Marshall et al., 2008 . The ability of these oncogenic and tumor suppressor proteins to deregulate Pol III transcription results from their capacity to regulate the TFIIIB complex. The TFIIIB complex consists of TATA box-binding protein (TBP) and its associated factors, Brf1 and Bdp1. TFIIIB, together with TFIIIC and RNA Pol III, are required to transcribe tRNA genes, whereas TFIIIB, together with TFIIIA, TFIIIC and RNA Pol III, are required to transcribe 5S rRNA genes. Earlier studies demonstrated that EGF activated EGFR, Ras and MAP kinases to increase TBP expression, resulting in RNA Pol I and III transcription (Zhong et al., 2004) . Further analysis indicated that alteration of cellular levels of TBP affected Bdp1 expression, but did not affect Brf1 expression (Zhong and Johnson, 2009 ). However, very little is known about whether H3 modifications modulate Pol III transcription. Recent studies have indicated that most active chromatin marks present in Pol II genes are also observed in active Pol III genes (Barski et al., 2010; Moqtaderi et al., 2010; Oler et al., 2010) . This implies that epigenetic modifications of histones may regulate activity of Pol III genes.
The maintenance of a repressed or activated status of a gene is often necessary for embryonic development, cellular differentiation and pathological states (Felsenfeld and Groudine, 2003) , and may be regulated by a specific histone code (Jenuwein and Allis, 2001) . Post-translational modifications of histone H3 (that is, phosphorylation, acetylation, methylation and ubiquitination) are known to be involved in chromatin remodeling and transcriptional regulation. Phosphorylation of histone H3 (H3ph) is induced by tumor promoters (EGF, UV, TPA) (Cheung et al., 2000; Kim et al., 2008) and immediate early genes, such as c-myc, c-jun and c-fos (Cheung et al., 2000; Wei et al., 1999) . The activation of these oncoproteins promotes cancer development. H3ph at serine 28 (H3S28ph) is associated with mitotic chromosome condensation (Goto et al., 1999) and cell transformation (Kim et al., 2008) . Studies have revealed that MAP kinases (that is, ERK, p38, JNK) and the MAPK downstream component, MSK1, mediated H3S28ph (Zhong et al., 2000 (Zhong et al., , 2001a . However, it remains to be determined which pathway upstream of MAPK mediates H3S28ph and whether H3S28ph affects the transcription machinery that regulates the activity of Pol III genes. Our previous study demonstrated that EGF activated EGFR and Ras to enhance TBP expression and RNA Pol III reporter transcription (Zhong et al., 2004) . This implies that H3S28ph may mediate Pol III gene transcription. To explore the epigenetic role of H3S28ph on Pol III transcription, we treated mouse epidermal JB6 cells with EGF to examine the effects of H3S28ph on Pol III genes. We have established that Brf1, TBP and tRNA Leu and 5S rRNA are new targets of H3S28ph. Our results elucidate a novel role of H3S28ph on the regulation of RNA Pol III transcription machinery. H3S28ph regulates Brf1 expression through EGFR, but not the PI3K pathway to indirectly affect the activity of Pol III genes. In addition, H3S28ph also directly upregulates transcription of tRNA-Leu and 5S rRNA. These regulatory events serve to modulate cell transformation.
Results

EGF-induced H3S28ph modulates transcription of Pol III genes through EGFR pathway
To determine which pathway upstream of MAPK regulates H3S28ph, mouse epidermal JB6 cells were treated with various amounts of EGF for 30 min. As shown in Figure 1a , EGF dramatically induced H3S28ph compared with a control without EGF treatment. Pretreatment of cells with the EGFR inhibitor, AG1478, but not the PI3K inhibitor, LY294002, blocked EGF-induced H3S28ph (Figure 1b ). To further determine whether this event specifically required EGFR, matched mouse embryo fibroblast cells that normally express EGFR were compared with cells that lack EGFR. Immunoblot analysis revealed that deletion of EGFR blocked EGF-induced H3S28ph in EGFR À/À cells compared with the EGFR þ / þ cells (Chen et al., 2001) (Figure 1c ). Introduction of the dominant negative mutant of PI3K (DPI3K) into JB6 cells did not decrease H3S28ph compared with JB6 cells transfected with empty vector alone ( Figure 1d ). As shown in Figure 2a , EGF dramatically increased Pol III genes, tRNA Leu , tRNA Tyr , 5S rRNA and 7SL RNA transcription. Blocking EGFR using AG1478 reduced the induction of Pol III genes ( Figure 2b ). Further analysis indicated that blocking H2S28ph by expressing mutant H3S28A reduced EGF-induced tRNA Leu and 5S rRNA transcription ( Figure 2c ). Together, these results indicate that activation of EGFR signaling serves to regulate cellular H3S28ph, which modulates transcription of tRNA Leu and 5S rRNA.
H3S28ph occupies the Brf1 and TBP promoters to modulate their expression It has previously been shown that EGF increases TBP expression to enhance tRNA reporter transcription (Zhong et al., 2004) . It remains to be seen whether EGF affects the expression of the other two TFIIIB subunits, Brf1 and Bdp1. Further analysis indicated that the MAPK, JNK1 positively regulated expression of the TFIIIB subunits TBP, Brf1 and Bdp1. Regulation of Bdp1, but not Brf1, occurred through JNK-mediated alterations in TBP expression (Zhong and Johnson, 2009 ), suggesting Brf1 and Bdp1 may be regulated independently. As shown in Figure 3 , EGF treatment increased cellular levels of protein and mRNA of Brf1, (Figures 4a and d ). Reduction of H3S28ph by expressing mutant H3S28A decreased its occupancy in the Brf1 and TBP promoters, but did not affect TFIIIC 63 (Figure 4d ). We next assessed whether the EGF-induced increase in H3S28ph affected induction of Brf1 and TBP expression. The results indicated that increased H3 expression by the wild-type histone H3 (WT H3) expression plasmid in JB6 cells enhanced EGF-mediated Brf1 and TBP expression, but not TFIIIC 63 (Figures 4b and c) .
In contrast, blocking H3S28ph by mutant H3S28A repressed the induction of Brf1 and TBP expression by EGF (Figures 4b and c ). These results support the Cells were treated with 20 ng/ml EGF for 60 min and total RNAs were extracted from these cells. The pre-tRNA Leu , pre-tRNA Tyr , 7SL RNA, 5S rRNA and GAPDH transcripts were measured by Reverse transcriptase quantitative (RT-q)PCR. The fold change was calculated by normalizing to the amount of GAPDH mRNA. (b) Inhibitor of EGFR represses the activity of pre-tRNA Leu and 5S rRNA genes. The cells were pretreated with AG1478 for 1 h and treated with EGF for 60 min. The tRNA Leu and 5S rRNA was determined by RT-qPCR. (c) Inhibition of H3S28ph reduces Pol III gene transcription. JB6 cells were transiently transfected with WT H3 and mutant H3S28A expression constructs for 48 h and treated with EGF, the amounts of pre-tRNA Leu , 5S rRNA and GAPDH transcripts were measured by RT-qPCR. The bars represent means ± s.e. of at least three independent determinations.
H3S28ph modulates Pol III gene transcription Q Zhang et al idea that EGF mediates an increase in Brf1 and TBP expression primarily through enhanced H3S28ph occupancy of their promoters.
EGF enhanced the occupancy of H3S28ph in tRNA and 5S rRNA promoters Next, we further determined whether H3S28ph mediated tRNA Leu and 5S rRNA transcription. As Brf1 specifically regulates Pol III gene transcription, we performed ChIP analysis to determine if Brf1 and H3S28ph occupy the Pol III gene promoters. The results revealed that EGF increased the occupancy of tRNA Leu and 5S rRNA promoters by Brf1 and H3S28ph ( Figures  5a and b) . In contrast, repression of H3S28ph by mutant H3S28A expression decreased occupancy of H3S28ph in the promoters (Figure 5c ). In addition, EGF reduced the H3K27me3 (a marker of gene repression) occupancy of tRNA Leu and 5S rRNA promoters (Figures 5a and b) .
Recently, by using ChIP-sequencing analysis for human CD4 þ T cells and human leukemia K562 cells, Barski and Moqtaderi, respectively, reported that weak occupancy of H3K27me3 correlates with tRNA expression (Barski et al., 2010; Moqtaderi et al., 2010) . Our results of HeK27me3 occupancy in tRNA Leu and 5S rRNA promoter are consistent with the analysis of ChIPsequencing. Although the analysis of ChIP-sequencing reveals strong H3K4me1/2/3 and H3Kac and weak H3K27me3 in tRNA genes, it remains to be determined whether H3S28ph modulates the activities of Pol III genes. Our studies demonstrate that H3S28ph may directly function at tRNA Leu and 5S rRNA promoters to modulate their transcription.
Reduction of H3S28ph decreased transcription of tRNA and 5S rRNA and repressed cell transformation Previous studies demonstrated that increasing Brf1 expression resulted in enhancement of Pol III gene transcription and was sufficient for cell transformation (Marshall et al., 2008) . Induction of Brf1 expression allowed anchorage-independent colonies to form and promoted tumor formation in mice (Marshall et al., 2008) . In the present study, we demonstrated that H3S28ph modulated Brf1 expression and tRNA and 5S rRNA transcription (Figures 2 and 3 ). Thus, we investigated whether H3S28ph affected EGFinduced cell transformation. The results indicate that inhibiting Brf1 expression with its siRNAs decreased cellular levels of Brf1 protein, as well as Pol III gene transcription ( Figure 6a ). EGF strongly induced JB6 cell anchorage-independent growth, whereas reducing Brf1 expression significantly decreased EGF-induced colony formation ( Figure 6b ). Furthermore, increasing H3 expression by using stable JB6 cells expressing WT H3 enhanced EGF-induced anchorage-independent growth, compared with stable JB6 cells expressing vector alone. However, blocking H3S28ph by stably expressing mutant H3S28A decreased anchorage-independent growth (Figure 6c ). These results demonstrate that H3S28ph modulates Brf1 expression and enhances tRNA and 5S rRNA transcription, thereby promoting cell transformation.
Discussion
This study presents a mechanistic analysis characterizing how the epigenetic modification of histone H3, H3S28ph, modulates endogenous tRNA and 5S rRNA gene transcription. Here, we report that EGF-induced H3S28ph occurs through EGFR, but not the PI3K pathway. Our studies identify the mechanism by which EGF-induced occupancy of H3S28ph in the Brf1 and TBP promoters modulates their expression, which indirectly regulates tRNA and 5S rRNA transcription. In addition, H3S28ph occupies tRNA and 5S rRNA promoters to directly regulate tRNA and 5S rRNA transcription. H3S28ph-mediated Brf1 expression and Pol III gene transcription are critically important to cell transformation. Blocking H3S28ph is sufficient to inhibit tRNA and 5S rRNA transcription and to repress anchorage-independent growth of JB6 cells. These findings support the novel notion that the histone H3 epigenetic modification, H3S28ph, regulates Pol III gene activity.
Previous studies have shown that MAPKs, ERKs, p38 and JNKs are involved in the phosphorylation of histone H3 at serine 10 (H3S10ph) and serine 28 (Zhong Supplementary  Table 2 ). The values represent means ± s.e. of three independent determinations.
H3S28ph modulates Pol III gene transcription Q Zhang et al . JB6 cells were treated with EGF and ChIP assays were performed using antibodies to H3S28ph and H3 and quantitative PCR was used to quantify the amplified DNA with the specific primers (see Supplementary Table 3 ). The relative occupancy of the proteins was calculated based on the control (no EGF treatment). (b, c) Inhibiting H3S28ph abrogates EGF-enhanced Brf1 and TBP expression. JB6 cells were transfected with WT H3 or mutant H3S28A expression plasmids for 48 h and then treated with EGF. H3S28ph, H3, c-Myc, Brf1, TBP, TFIIIC 63 and b-actin were determined by immunoblot analysis. A representative blot is shown (b). Reverse transcriptase quantitative PCR was performed on RNA isolated from these cells to measure Brf1, TBP, TFIIIC 63 and GAPDH transcripts (c). (d) Expression of mutant H3S28A reduces H3S28ph occupancy in Brf1 and TBP promoters. These cells were treated as indicated in b and c. Chromatin was extracted from these cells to perform ChIP assay with H3S28ph antibody. All values shown are the means ± s.e.m. of at least three independent chromatin preparations.
H3S28ph modulates Pol III gene transcription Q Zhang et al et al., 2000, 2001b) . Further analysis indicated that down-stream of MAPKs, MSK1-mediated H3S28ph (Zhong et al., 2001a) . In this study, we report that EGFR, but not PI3K, mediated EGF-induced H3S28ph (Figure 1) . Studies have identified H3S10ph and H3S28ph as mitotic markers (Goto et al., 1999; Wei et al., 1999) . Phosphorylation of histone H3 at threonine 3 (H3T3ph) has been shown to be necessary for accumulation of the chromosomal passenger complex at the centromere in mitosis . Phosphorylation of histone H3 at threonine 6 (H3T6ph) mediated androgen receptor-activated gene expression (Metzger et al., 2010) . In addition, H3S10ph and H3S28ph were associated with cell transformation (Kim et al., 2008) . These studies suggest that H3ph is critically important to numerous cellular processes. Pol III gene transcription is essential for cell transformation and tumorigenesis ( Figure 5 EGF increases occupancies of Brf1 and H3S28ph, but decreases H3K27me3 in tRNA Leu and 5S rRNA promoters. (a) EGFmediated occupancy in the tRNA Leu promoter. JB6 cells were treated with or without EGF and ChIP assays were performed using Brf1, H3S28ph, H3K27me3 and H3 antibodies and quantitative (q)PCR with specific tRNA Leu primers to quantify the amplified DNA. (b) EGF enhances Brf1, H3S28ph occupancy in the 5S rRNA promoter. ChIP assays were performed as indicated in Figure 4 and qPCR was used with 5S rRNA primers to quantify the DNA. (c) Expression of mutant H3S28A reduces H3S28ph occupancy in tRNA Leu and 5S rRNA promoters. These cells were treated as designed Figures 4b and c . Chromatin was extracted from these cells to perform ChIP assays with H3S28ph antibody. The relative occupancy of the proteins was calculated based on the control (no EGF treatment). All values shown are the means±s.e.m. of at least three independent chromatin preparations. (Zhong et al., 2004) . Here, we report that EGF induced H3S28ph through the EGFR pathway ( Figure 1) and that H3S28ph indeed modulated endogenous tRNA Leu and 5S rRNA transcription. Although our previous study indicated that EGF increased TBP expression and tRNA reporter transcription in JB6 cells (Zhong et al., 2004) , we did not establish whether EGF affected the other two TFIIIB subunits, Brf1 and Bdp1. Our recent analysis further demonstrated that alteration of the cellular level of TBP affected Bdp1 expression, but did not change Brf1 expression (Zhong and Johnson, 2009 ). In the present study, the results reveal that EGF increased endogenous Pol III gene transcription (Figure 2) and enhanced cellular levels of TFIIIB subunits, Brf1 and Bdp1 in JB6 cells (Figure 3) . Thus, we investigated whether H3S28ph mediated Brf1 expression, resulting in changes in endogenous Pol III gene transcription. EGF enhanced occupancy of H3S28ph in the promoters of Brf1, TBP, tRNA Leu and 5S rRNA, and increased Brf1 and TBP Supplementary  Table 1 ) for 48 h and treated with EGF. Cell lysates and RNA were isolated from these cells. Immunoblot analysis was performed to determine cellular level of Brf1 protein (left) and pre-tRNA Leu (middle), 5S rRNA (right) and GAPDH transcripts were measured by reverse transcriptase quantitative (RT-q)PCR. (b) Downregulating Brf1 expression decreases EGF-induced anchorage-independent growth. JB6 cells expressing Brf1 siRNAs were poured in triplicate into six-well plate with 0.35% agar containing 0 or 20 ng/ml EGF. The cells in a were analyzed for growth in soft agar. (c) Blocking H3S28ph signaling represses EGF-induced cell transformation. JB6 stable cell lines expressing pcDNA3 vector (vector), pcDNA3-wild type H3 (WT H3) or pcDNA3-H3S28A (H3S28A) were poured into six-well plate with EGF as designated at (b). Cells in a and b were be incubated at 37 1C in 5% CO 2 for 1-2 weeks and were fed with fresh complete media with or without EGF twice weekly. Colonies were counted at 1-2 weeks after plating. Values are the means ± s.e.m. (nX3).
H3S28ph modulates Pol III gene transcription Q Zhang et al expression as well as tRNA Leu and 5S rRNA transcription. In contrast, expression of mutant H3S28A reduced occupancy of H3S28ph in the Brf1, TBP and tRNA Leu and 5S rRNA promoters and decreased their expression ( Figures 4 and 5) , resulting in repression of cell transformation ( Figure 6 ). These studies demonstrate that H3S28ph directly and indirectly regulate Pol III genes leading to cell transformation.
It is possible that a balance of different histone H3 modifications in vivo control gene expression in various physiological and pathological states. The balance between acetylation and deacetylation of core histones is regulated by HATs and HDACs. It has been shown that removal of acetyl groups by HDACs is associated with transcriptional repression (Struhl and Moqtaderi, 1998; Finnin et al., 1999) . The treatment of mammalian cells with inhibitors of HDACs such as TSA or trapoxin was shown to result in increased expression of a variety of genes (Kijima et al., 1993; Yoshida and Horinouchi, 1999) . C-Myc induction enhanced occupancy of tRNA-Leu and 5S rRNA promoters by acetylated histone H3 and increased the expression of these genes (Kenneth et al., 2007) . In addition to increasing acetylation of histone H3, TSA activated MAPKs to induce H3S28ph, whereas H3S28ph, in turn, facilitated acetylation of histone H3 at lysine 9 (Zhong et al., 2003) . Immediate early genes, c-myc, c-jun and c-fos, induce H3ph (Wei et al., 1999; Cheung et al., 2000) . This implies that c-Myc induction may enhance H3ph to elevate the activity of tRNA and 5S rRNA genes. The role of c-Myc in H3ph is worth further study. H3T6ph prevented demethylation of H3K4 to increase androgen receptordependent gene activation (Metzger et al., 2010) . H3S10ph was critical for full transcriptional activation of virus-like 30S elements (Brunmeir et al., 2010) . H3S10ph occupancy of the c-fos promoter mediated gene activity (Shimada et al., 2010) . H3K4me1/2/3 is a marker of gene activation, whereas H3K27me3 is a marker of gene repression. Chip-sequence reveals strong H3K4me1/2/3 and H3Kac and weak H3K27me3 in tRNA genes (Barski et al., 2010) . Phosphorylation of H3K27me3S28 occurs in response to stress signaling, mitogenic signaling and retinoic acid-induced neuronal differentiation. MSK1/2-mediated phosphorylation of H3K27me3S28 activates a subset of polycomb group target genes and modulates the gene expression program, which determines cell fate (Gehani et al., 2010) . Our results reveal that EGF decreased occupancy of H3K27me3 in tRNA Leu and 5S rRNA promoter, while EGF enhanced occupancy of H3S28ph in tRNA Leu and 5S rRNA promoters, resulting in upregulation of their transcription. Our studies indicate that epigenetic modifications of histone H3 takes part in the regulation of tRNA and 5S rRNA genes. Together, these analyses support the idea that changes in the balance of different modifications of histone H3 provide a mechanism for the regulation of tRNA and 5S rRNA transcription. H3S28ph not only directly occupies promoters of Pol II genes, such as c-fos and Brf1 and TBP, but also is directly associated with promoters of Pol III genes, tRNA Leu and 5S rRNA. It suggests that a common epigenetic regulation of histone H3 mediates both RNA Pol II and RNA Pol III-dependent gene activity.
In summary, increased Pol III gene transcription, observed in transformed cells and human tumors, is required for oncogenic transformation. In this present study, we provide evidence that increasing H3S28ph enhances Pol III gene transcription and the rate of cell transformation. The novel findings suggest the possibility that blocking H3S28ph by an inhibitor may be a potential approach to repress cell transformation and tumor development (Figure 7 ).
Materials and methods
Reagents and antibodies EGF was from Sigma-Aldrich (Rehovot, Israel). Cell culture medium (MEM, Eagle minimal essential medium) and Dulbecco's modified Eagle's medium, G418, Lipofectin reagent, Lipofectamine 2000, TRIzol reagent and OPTI-MEM were from Invitrogen (San Diego, CA, USA). Antibodies against TBP, Bdp1, b-actin, TFIIIC 63 and c-Myc probe were obtained from San Cruz (Santa Cruz, CA, USA). Histone H3 and phospho-H3S28 antibodies were from Cell Signaling (Danvers, MA, USA). Reverse transcriptase quantitative PCR and transfection assays Total RNA was isolated from mouse epidermal JB6 cells or engineered JB6 cells using single step extraction method with TRIzol reagent (Invitrogen). Precursor of tRNA Leu and tRNA Tyr , 7SL RNA and 5S rRNA transcripts were measured as described previously (Crighton et al., 2003) . For transient transfection assays, JB6 cells were transfected with plasmids or siRNAs as described previously (Zhong et al., 2004) . Serum-free medium was added to each dish with Lipofectin-DNA or Lipofectamine2000-siRNA complexes, and cells were further incubated for 4 h. The medium was changed with 5% fetal bovine serum/MEM and cells were incubated for 48 h before harvesting. Protein concentrations of the resultant lysates were measured by the Bradford method.
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Stable transfection and cell anchorage-independent growth
Stable transfections were conducted using the Lipofectin reagent (Invitrogen) and pCMV-Tag3 vector (Vector), pCMV-Tag3-WT H3 or pCMV-Tag3-mutant histone H3S28A (H3S28A). The stable transfections were carried out as described in the protocol from Invitrogen. In brief, for each 6 cm dish of JB6 cells to be transfected, 4 mg DNA vector, WT H3 or H3S28A into 100 ml OPTI-MEM media and 4 ml lipofectin reagent in 100 ml OPTI-MEM media were incubated for 5 min at room temperature, respectively. Diluted DNA and lipofectin reagent were mixed and incubated for 30 min at room temperature to form the DNA-lipofectin complexes. DNA-lipofectin complex was added into each dish and mixed. The cells were incubated at 37 1C for 4 h and then media were changed to fresh growth media for 48 h. Selective media containing 400 mg/ml G-418 were added to each dish and the surviving G418-resistant cell populations were pooled. Early passage number of selected cells were used and maintained in the presence of G-418 (200 mg/ml). G418 selected cells were tested for c-Myc epitope-tagged histone H3 by immunoblot analysis with a c-Myc-tag antibody.
JB6 cells transfected with mismatch RNA and mouse Brf1 siRNAs ( Supplementary Table S1 ). The Brf1 siRNAs are pooled and correspond to nucleotide positions 723-741, 1623-1641 and 2415-2435 within exon 4, 12 and 18 of mouse Brf1, respectively. The transiently transfected JB6 cells or JB6 stable cell lines expressing vector, WT H3 or H3S28A (2 Â 10 4 cells/well in six-well plate) were suspended in 0.35% (w/v) agar in 10% fetal bovine serum/MEM with or without EGF (20 ng/ ml), over a bottom layer of media with 0.5% (w/v) agar. Cells were fed fresh complete media with EGF twice weekly. Colonies were counted 1-2 weeks after plating.
Immunoblot analysis
Immunoblot analysis was carried out as previously described (Zhong and Johnson, 2009 ). Cells were grown to 85% confluency in 5% fetal bovine serum/MEM and then serum deprived using 0.1% fetal bovine serum/MEM for 3 h. Where noted, cells were pretreated with 2 mM of the EGFR inhibitor, AG 1478 or 25 mM PI3K inhibitor, LY 294002 for 1 h and then incubated with or without 20 ng/ml of EGF. Lysates (50 mg of protein) were subjected to immunoblot analysis. Membranes were probed with specific antibodies as indicated. Hybond-P membrane was used for protein transfer. Bound primary antibody was visualized using horseradish peroxidase-conjugated secondary antibody (Vector Laboratories, Burlingame, CA, USA) and enhanced chemiluminescence reagents (Amersham, Piscataway, NJ, USA).
